Table 7: The Distribution of Disease Activity Parameters According to MTHFR A1298C Polimorphism in RA Patients

AA (n=24) AC (n=31) CC (n=9) pa
HAQ (median) 0.5 (0-2.5)b 1.1 (0-3)b,c 0.25 (0-1.6)c 0.005
DAS28 (median) 4.1 (2.4-6.9) 4.3 (1.7-7.8) 3.4 (2.6-5.8) 0.347
Larsen Score (median) 2.0 (1.0-5.0) 3.0 (1.0-5.0) 2.0 (1.0-5.0) 0.220
ESR (median) 26.5 (6.0-120.0) 36.0 (2.0-110.0) 29.0 (3.0-50.0) 0.344
CRP (median) 0.7 (0.2-10.0) 0.8 (0.1-10.5) 0.5 (0.2-2.5) 0.386

a Analysis of variance among the genotypes
b Statistically significant difference between AA and AC (p=0,003).
c Statistically significant difference between AC and CC (p=0,002).
HAQ: The Health Assessment Questionnaire, DAS 28: Disease Activity Score, ESR: Sedimentation, CRP: C- reactive protein, MTX: Methotrexate, DMARD: Disease-modifying antirheumatic drugs, NSAII: Nonsteroidal anti-inflammatory drugs.